BIOMAT Database Logo BIOMAT Database Logo

MiR-146a-5p suppresses activation and proliferation of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis through directly targeting Wnt1 and Wnt5a. 2015

Jinghua Du, and Xuemin Niu, and Yang Wang, and Lingbo Kong, and Rongqi Wang, and Yuguo Zhang, and Suxian Zhao, and Yuemin Nan
Department of Traditional and Western Medical Hepatology, Third Hospital of Hebei Medical University, Shijiazhuang, China.

Nonalcoholic fibrosing steatohepatitis is a uniform process throughout nonalcoholic fatty liver disease (NAFLD). MicroRNAs (miRNAs) have been suggested to modulate cellular processes in liver diseases. However, the functional role of miRNAs in nonalcoholic fibrosing steatohepatitis is largely unclear. In this study, we systematically analyzed the hepatic miRNAs by microarray analysis in nonalcoholic fibrosing steatohepatitis in C57BL/6J mice induced by methionine-choline deficient (MCD) diet. We identified 19 up-regulated and 18 down-regulated miRNAs in liver with fibrosis. Among these dysregulated miRNAs, miR-146a-5p was the most significant down-regulated miRNA. Luciferase activity assay confirmed that Wnt1 and Wnt5a were both the target genes of miR-146a-5p. Hepatic miR-146a-5p was down-regulated in fibrosing steatohepatitis, but its target genes Wnt1 and Wnt5a and their consequent effectors α-SMA and Col-1 were significantly up-regulated. In addition, miR-146a-5p was downregulated, whilst Wnt1 and Wnt5a were up-regulated in the activated primary hepatic stellate cells (HSCs) compared to the quiescent primary HSCs. Overexpression of miR-146a-5p in HSCs inhibited HSC activation and proliferation, which concomitant with the decreased expressions of Wnt1, Wnt5a, α-SMA and Col-1. In conclusion, miR-146a-5p suppresses activation and proliferation of HSCs in the progress of nonalcoholic fibrosing steatohepatitis through targeting Wnt1 and Wnt5a and consequent effectors α-SMA and Col-1.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D005355 Fibrosis Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury. Cirrhosis,Fibroses
D000071818 Wnt-5a Protein A Wnt protein and ligand for FRIZZLED RECEPTORS that may function as an inhibitor or activator of the WNT SIGNALING PATHWAY. For example, it activates signaling in the presence of Frizzled-4 but is inhibitory when coupled with ROR2 TYROSINE KINASE. It is required for axis formation during EMBRYOGENESIS and inhibits the proliferation, migration, and invasiveness of cancer cells. Wingless-Type MMTV Integration Site Family, Member 5A,Wnt5a Protein,Wingless Type MMTV Integration Site Family, Member 5A,Wnt 5a Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015533 Transcriptional Activation Processes that stimulate the GENETIC TRANSCRIPTION of a gene or set of genes. Gene Activation,Genetic Induction,Transactivation,Induction, Genetic,Trans-Activation, Genetic,Transcription Activation,Activation, Gene,Activation, Transcription,Activation, Transcriptional,Genetic Trans-Activation,Trans Activation, Genetic
D015536 Down-Regulation A negative regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Down-Regulation,Down-Regulation (Physiology),Downregulation,Down Regulation,Down-Regulation, Receptor
D015854 Up-Regulation A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Up-Regulation,Upregulation,Up-Regulation (Physiology),Up Regulation

Related Publications

Jinghua Du, and Xuemin Niu, and Yang Wang, and Lingbo Kong, and Rongqi Wang, and Yuguo Zhang, and Suxian Zhao, and Yuemin Nan
miR-654-5p Contributes to the Activation and Proliferation of Hepatic Stellate Cells by Targeting RXRα.
January 2022, Frontiers in cell and developmental biology,
Jinghua Du, and Xuemin Niu, and Yang Wang, and Lingbo Kong, and Rongqi Wang, and Yuguo Zhang, and Suxian Zhao, and Yuemin Nan
MiR-483-5p suppresses the proliferation of glioma cells via directly targeting ERK1.
May 2012, FEBS letters,
Jinghua Du, and Xuemin Niu, and Yang Wang, and Lingbo Kong, and Rongqi Wang, and Yuguo Zhang, and Suxian Zhao, and Yuemin Nan
miR-146b-5p activation of hepatic stellate cells contributes to the progression of fibrosis by directly targeting HIPK1.
August 2022, Experimental and therapeutic medicine,
Jinghua Du, and Xuemin Niu, and Yang Wang, and Lingbo Kong, and Rongqi Wang, and Yuguo Zhang, and Suxian Zhao, and Yuemin Nan
Hepatic stellate cell activation occurs in nonalcoholic steatohepatitis.
January 2001, Hepato-gastroenterology,
Jinghua Du, and Xuemin Niu, and Yang Wang, and Lingbo Kong, and Rongqi Wang, and Yuguo Zhang, and Suxian Zhao, and Yuemin Nan
Imatinib suppresses activation of hepatic stellate cells by targeting STAT3/IL-6 pathway through miR-124.
May 2023, Cell biology international,
Jinghua Du, and Xuemin Niu, and Yang Wang, and Lingbo Kong, and Rongqi Wang, and Yuguo Zhang, and Suxian Zhao, and Yuemin Nan
Hepatic stellate cell activation in nonalcoholic steatohepatitis and fatty liver.
July 2000, Human pathology,
Jinghua Du, and Xuemin Niu, and Yang Wang, and Lingbo Kong, and Rongqi Wang, and Yuguo Zhang, and Suxian Zhao, and Yuemin Nan
Liquiritigenin suppresses the activation of hepatic stellate cells via targeting miR-181b/PTEN axis.
January 2020, Phytomedicine : international journal of phytotherapy and phytopharmacology,
Jinghua Du, and Xuemin Niu, and Yang Wang, and Lingbo Kong, and Rongqi Wang, and Yuguo Zhang, and Suxian Zhao, and Yuemin Nan
Bone marrow-derived macrophage contributes to fibrosing steatohepatitis through activating hepatic stellate cells.
August 2019, The Journal of pathology,
Jinghua Du, and Xuemin Niu, and Yang Wang, and Lingbo Kong, and Rongqi Wang, and Yuguo Zhang, and Suxian Zhao, and Yuemin Nan
MiR-9-5p Inhibits Glioblastoma Cells Proliferation Through Directly Targeting FOXP2 (Forkhead Box P2).
January 2019, Frontiers in oncology,
Jinghua Du, and Xuemin Niu, and Yang Wang, and Lingbo Kong, and Rongqi Wang, and Yuguo Zhang, and Suxian Zhao, and Yuemin Nan
miR-423-5p Inhibits Osteosarcoma Proliferation and Invasion Through Directly Targeting STMN1.
January 2018, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology,
Copied contents to your clipboard!